Glycoprotein IIb/IIIa antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

562440, A61K 31195, C07C25102

Patent

active

056188439

ABSTRACT:
This invention relates to certain bicyclic compounds having a nucleus formed of two fused six membered rings, for example, isoquinoline, isoquinolone, tetrahydronaphthalene, dihydronaphthalene, or tetralone, substituted with both basic and acidic functionality, which are useful in inhibition of platelet aggregation.

REFERENCES:
patent: 5039805 (1991-08-01), Alig et al.
patent: 5041453 (1991-08-01), Huang et al.
patent: 5064814 (1991-11-01), Klein et al.
Chemical Abstracts, vol. 84, N. 13, Abstract 90500z, Mar. 29, 1976, p. 566, Barxzai-Beke et al.
McDowell et al., 1994 Journal American Chemical Society vol. 116, 5077-5083.
Chemical Abstracts, vol. 75, N. 10, Abstract 74391y, Sep. 6, 1971, p. 278, Satoh et al.
Ku et al., 1993 Journal American Chemical Society vol. 115, 8861-8862.
Blackburn et al., 1993 Annual Reports In Medicinal Chemistry vol. 28, 79-88.
Chemical Abstracts, vol. 100, N. 17, Abstract 138973n, Apr. 23, 1984, p. 638, Otsuka Pharmaceutical Co.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Glycoprotein IIb/IIIa antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glycoprotein IIb/IIIa antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycoprotein IIb/IIIa antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2398116

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.